Alector Inc is a clinical stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies which are designed to simultaneously counteract pathologies by restoring healthy immune function to... Alector Inc is a clinical stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies which are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline product inlcude AL001, AL002, AL003, and AL101. 詳細を表示
SOUTH SAN FRANCISCO, Calif., Nov. 25, 2024 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering novel, genetically validated therapies for the...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.42 | -18.1034482759 | 2.32 | 2.32 | 1.845 | 1180072 | 2.06024507 | CS |
4 | -1.8 | -48.6486486486 | 3.7 | 4.18 | 1.845 | 2038610 | 2.60901603 | CS |
12 | -3.59 | -65.3916211293 | 5.49 | 6.14 | 1.845 | 1067089 | 3.45314897 | CS |
26 | -2.73 | -58.9632829374 | 4.63 | 6.78 | 1.845 | 806713 | 4.1662754 | CS |
52 | -6.27 | -76.7441860465 | 8.17 | 8.9 | 1.845 | 728505 | 5.01094965 | CS |
156 | -19.66 | -91.1873840445 | 21.56 | 24.005 | 1.845 | 652629 | 7.84269351 | CS |
260 | -18.37 | -90.6265416872 | 20.27 | 45 | 1.845 | 701989 | 14.46287801 | CS |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約